CAR T Cell Therapy in Smoldering Myeloma: Balancing Deep Responses with High Toxicity Risks
Researchers have successfully utilized Chimeric Antigen Receptor (CAR) T cell therapy to target smoldering multiple myeloma, an asymptomatic precursor to bone marrow cancer. Published in Nature Medicine this June, the ... Read More